Created in 2013 (Denmark), Xultophy own 307 sister brands and 2214 competing brands. Xultophy is owned by NOVO-NORDISK A/S, listed on the stock exchange of Francfort Xultophy is part of the Biotechnology activity sector.
Buy NOVO-NORDISK A/S share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Other brands
NOVO-NORDISK A/S
-
A
-
B
-
C
-
D
- Durocto
- DiaScope
- Durocta
- DIALOG
- Duvicta
- Duzodec
- Duzodan
- DUAL
- Don't weight for diabetes
- Dursulis
- Duampic
- Dovervo
- Dinsulom
- Dosidec
- Delonec
- Degluvant
- Deglera
- Deglecta
- Deglea
- Degizon
- Degizen
- Deginex
- drawtube
- Diabetes Quality Circle
- DAWN Diabetes Attitudes Wishes and Needs
- DAWN Diabetes Attitudes Wishes & Needs
- Diabetes Care Excellence Model
- Diabetes Quality Model
- DoseMan
- DATAPEN
-
E
-
F
-
G
-
H
-
I
-
J
-
K
-
L
-
M
-
N
- Nyorma
- NNIT SafeCoder
- NNIT Playmaker
- Nynzera
- Nexspart
- NNIT
- Nineplus
- NNIT Cloud Computing Model
- NovoVance
- Norditropin NordiFlex
- NordiPro
- NovoLet
- NordiPen
- NordiPenMate
- NovoSmart
- nne pharmaplan
- NOVIANA
- NovoLog
- NORDITROPIN SIMPLEXX
- NovoRapid (insulin apart) Rapid, flexible control
- NordiFlex PenMate
- NovoMet
- NordiNet
- NordiCare
- NordiScience
- Novofemme
- nne
- Norditropin Junior
- NOVOFEM
- NovoMix
- NovoNet
- NovoLife
- NEWGUARD
- NNIT Expectation Barometer
- NovoEight
- NOVOTRACK
- NOVOTOP
- NOVODYN
- NOVOESTELL
- NOVONORM (repaglinide/Novo Nordisk)
- NovoAlert
- NovoFort
- NovoTard
- NOVO
-
O
-
P
-
R
-
S
-
T
-
U
-
V
-
X
-
Z
